Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Michael Zinda Insider Profile
11 Followers
Michael Zinda, EVP, CHIEF SCIENTIFIC OFFICER at Repare Therapeutics, holds 71.91K shares in Repare Therapeutics (Ticker: RPTX).
Michael Zinda Repare Therapeutics (RPTX)EVP, CHIEF SCIENTIFIC OFFICER
Repare Therapeutics (RPTX)
EVP, CHIEF SCIENTIFIC OFFICER
Ranked #13,290 out of 100,285 Corporate Insiders
Profitable Transactions
4 out of 4 Profitable Transactions
Average Return
+36.60%
Average return per transaction
Time Frame
Compare to
Insider Roles
EVP, CHIEF SCIENTIFIC OFFICER
Roles that Michael Zinda holds in companies
Most Profitable Insider Trade
Stock:
Rating:Informative Sell
Date:Dec 30, 2020 - Dec 30, 2021
Return:+37.90%
The most profitable trade made by Michael Zinda
Michael Zinda's Trading History
List of latest transactions for each holding click on a transaction to see Michael Zinda's performance on stock
You May Also Like
Michael Zinda insider profile FAQ
What is the percentage of profitable transactions made by Michael Zinda?
The percentage of profitable transactions made by Michael Zinda is 100%.
What is the average return per transaction made by Michael Zinda?
The average return per transaction made by Michael Zinda is 36.60%.
What stocks does Michael Zinda hold?
Michael Zinda holds: RPTX stocks.
What was Michael Zinda’s latest transaction?
Michael Zinda latest transaction was an Uninformative Sell of $4.00K.
What was Michael Zinda's most profitable transaction?
Michael Zinda’s most profitable transaction was an Informative Sell of RPTX stock on December 30, 2020. The return on the trade was 37.90%.
What is Michael Zinda's role in Repare Therapeutics?
Michael Zinda's role in Repare Therapeutics is EVP, CHIEF SCIENTIFIC OFFICER.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.